Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabbit ATG + cyclosporine + eltrombopag for transfusion‑dependent aplastic anemia
jRCTs071190032Completed
- Sponsor
- Novartis
- Start
- Nov 2019
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of eltrombopag, antithymocyte globulin rabbit and cyclosporine in aplastic anemia, sponsored by Novartis. Primary endpoint: Hematologic response rate at week 12. Started Nov 2019; status: completed.
02
Drugs
eltrombopagantithymocyte globulin rabbitcyclosporine
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on jRCTs071190032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190032.